Skip to main content

Slight Gain for BCW Index

The BCW Index rose .6 percent for the five-day trading period ended Tuesday. Though only a slight gain, it performed better than the Dow Jones Industrial Average, Nasdaq, and Nasdaq Biotech Index which fell .1 percent, .8 percent, and 1.4 percent, respectively.
 
PerkinElmer led gainers with a 3.5 percent rise, followed by Qiagen, which climbed 3.2 percent, and Bio-Rad, which closed up 3 percent. Millipore had the sharpest drop, finishing the tracking period down 1.6 percent.
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(December 12, 2006)
Last
Price
December 5, 2006)
% change
Agilent A
33.86
33.16
2.1
Applied Biosystems ABI
37.54
37.82
-0.7
Beckman BEC
59.38
60.55
-1.9
Bio-Rad BIO
84.01
81.60
3.0
Bruker BRKR
7.98
8.00
-0.2
GE GE
35.64
35.27
1.0
Invitrogen IVGN
57.67
56.90
1.4
Millipore MIL
68.79
69.89
-1.6
Molecular Devices MDCC
22.53
22.20
1.5
PerkinElmer PKI
22.26
21.50
3.5
Qiagen QGEN
14.98
14.52
3.2
Sigma SIAL
77.83
77.01
1.1
Stratagene STGN
7.52
7.55
-0.4
Thermo TMO
44.50
44.53
-0.1
Waters WAT
49.39
49.82
-0.9
BCW Index Average  
41.59
41.35
0.6

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.